Facial Imaging in FASD and Related Disabilities

Slides:



Advertisements
Similar presentations
Centro di Riferimento Alcologico della Regione Lazio MAURO CECCANTI Brussels 9 September 2009 MAURO CECCANTI Brussels 9 September 2009 EPIDEMIOLOGY OF.
Advertisements

Fetal Alcohol Spectrum Disorder: A Preventable Epidemic Barry S Parsonson PhD Explore & Applied Psychology International.
Fetal Alcohol Spectrum Disorders Presenter Sr. Suzette Fisher, SND, Ed.S. Prevention, Education, Intervention, and Advocacy Emerging Issues in Maternal.
Better Safe Than Sorry: PowerPoint Slides for Transparencies
Brenda Stade, PhD Fetal Alcohol Spectrum Disorder Dr. Brenda Stade, RN
Fetal Alcohol Spectrum Disorder (FASD) Reducing alcohol-related harm through a nonjudgmental approach Dr. Samuel Harper.
Prenatal Alcohol Exposure
Rationale for growth monitoring. Why Monitor Growth Growth is the most sensitive indicator of health  normal growth only occurs if a child is healthy.
David Anderson, Bruce Golden, Ed Wasil, Howard Zhang 1 INFORMS Annual Meeting October, 2013.
References 1. Centers for Disease Control and Prevention. Fetal Alcohol Spectrum Disorders. Retrieved February 17, 2007, from
The Nature of Disease.
TM Jacquelyn Bertrand, PhD FAS Prevention Team. TM Fetal Alcohol Syndrome Screening and Diagnostic Guide As part of the fiscal year 2002 appropriations.
The Protective Effect of Astaxanthin on Fetal Alcohol Spectrum Disorder in Mice Sun Yat-Sen Memorial Hospital, Sun Yat-Sen Uni. China Ying Peng Ying Peng.
Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis
Fetal Alcohol Spectrum Disorders
Prenatal Alcohol Exposure Causes Birth Defects Alcohol and pregnancy do not mix.
Daily Objective The students will be able to identify the cause, characteristics, and the treatment or prevention of the birth defects presented in class.
Fetal Alcohol Syndrome FAS Pre-Quiz. An Ounce of Prevention  2000, 2005 The Curators of the University of Missouri.
Fetal Alcohol Spectrum Disorder Dr. Brenda Stade, RN
Standardizing Diagnosis of FAS Jocelynn L. Cook, Ph.D.
FASD 4-Digit Diagnostic Code Susan J. Astley, Ph.D. Professor of Epidemiology University of Washington Director Washington State FAS Diagnostic & Prevention.
Copyright Alcohol Medical Scholars Program1 Fetal Alcohol Syndrome (FAS) An Overview Lauren D. Williams, M.D. University of Miami School of Medicine.
Development. Developmental Psychology Developmental psychology – The study of how organisms change over time as the result of biological and environmental.
Fetal Alcohol Spectrum Disorders: Competency V – Screening, Assessment, and Diagnosis The Arctic FASD Regional Training Center is a project of the UAA.
Development. Developmental Psychology Developmental psychology – The study of how organisms change over time as the result of biological and environmental.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Fetal Alcohol Syndrome
Prediction statistics Prediction generally True and false, positives and negatives Quality of a prediction Usefulness of a prediction Prediction goes Bayesian.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
Differences in Physical Characteristics between Children with Autism and Children with Other Developmental Disorders Bhavan A. Modi, Dr. Sarah O’Kelley,
MRFASTC FAS/FASD Screening, Diagnosis and Assessment Competency #5 Midwest Regional Fetal Alcohol Syndrome Training Center.
Joan Carles Soliva Vila Cognitive Neuroscience Research Unit (URNC) Dept. of Psychiatry. Autonomous University of Barcelona (UAB)
An Ounce of Prevention  2000, 2005, 2011 The Curators of the University of Missouri Chapter 3 Alcohol.
Fetal Alcohol Spectrum Disorders Fetal Alcohol Syndrome Fetal Alcohol Effects Alcohol-Related Neurodevelopmental Disorder Alcohol-Related Birth Defects.
Definition & Risk Factors of FGR FGR, also called IUGR is the term used to describe a fetus that has not reached its growth potential because of genetic.
UNDERSTANDING PRENATAL ALCOHOL EXPOSURE
3D-Assissted Quantitative Determination of Zygomatic Complex Using an Open-Source Software 1 Victor Bong-Hang Shyu, M.D., 1 Chih- hao Chen, M.D.
What have we done and what are we doing? FASD and Justice Projects.
Association of Body Mass Index (BMI) and Depression Severity
Bootstrap and Model Validation
The Anchorage FASD Diagnostic Team
Kenneth Lyons Jones, MD Luther K. Robinson, MD
A Multisite Neurobehavioral Assessment of FASD
Mapping the Brain the Face and Neurocognitive
CORRELATION OF PHYSICAL EVALUATION AND MRI OF CERVICAL LYMPH NODE WITH HISTOPATHOLOGICAL FINDINGS IN ORAL SQUAMOUS CELL CARCINOMA: AN AMBIDIRECTIONAL STUDY.
Dysmorphology Core Status Report February 2015
NICHOLAS J. TALLEY, M.B., Ph.D., SIDNEY F. PHILLIPS, M.D. 
Dysmorphology Core: Progress Report February 1, 2011
CIFASD: Dysmorphology Core
with Special Reference to GH
3D Facial Imaging Project
Kenneth Lyons Jones University of California, San Diego
Effects of fetal alcohol syndrome on facial shape
Fetal Alcohol Syndrome
Facial Features of FAS.
3D Facial Imaging Project
Fetal Alcohol Spectrum Disorder (FASD)
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD)
FETAL ALCOHOL SYNDROME
Screening, Sensitivity, Specificity, and ROC curves
Better Safe Than Sorry: The Biological Basis of Fetal Alcohol Syndrome and other Alcohol-Related Birth Defects.
Fetal Alcohol Spectrum Disorders Ira J. Chasnoff, MD
Better Safe Than Sorry: PowerPoint Slides for Transparencies
NICHOLAS J. TALLEY, M.B., Ph.D., SIDNEY F. PHILLIPS, M.D. 
Medical Approach Physicians began using medical models to review the physical causes of these disorders. Etiology: Cause and development of the disorder.
It is estimated that 1 to 3 per 1,000 babies born in Canada have fetal alcohol syndrome (FAS). Fetal alcohol spectrum disorder (FASD) is estimated to affect.
Diagnostic algorithm for fetal alcohol spectrum disorder (FASD)
supported study by Dr. Heiko Gaßner and Dr. Cecilia Raccagni
NICHOLAS J. TALLEY, M.B., Ph.D., SIDNEY F. PHILLIPS, M.D. 
Presentation transcript:

Facial Imaging in FASD and Related Disabilities Luther K Robinson, MD

Background Many developmental disability disorders are diagnosed clinically Training Experience Quantitative findings FASD, a common disorder fits this paradigm Early diagnosis improves outcomes Under-served may not be readily diagnosed Important to expand diagnostic capacity

FAS: Diagnostic Criteria Growth deficiency (height or weight <10th centile) Characteristic facial manifestations Short palpebral fissures Smooth philtrum/thin upper vermilion Central nervous system abnormalities Structural (e.g., small head, abnormal MRI) Functional (e.g., learning disability)

Questions Which clinical measures correlate with diagnosis of FASD? Do additional measures add to diagnostic accuracy or expand the FAS phenotype? Do clinical measures compare with digital measures? Can laser imaging techniques be applied to distinguish FAS from other syndromes? Can laser technology be translated more broadly?

Goals and Objectives Evaluate sensitivity and specificity of clinical and anthropometric measures in the diagnosis of FASD Compare these measures with data from 3-D facial imaging

Methods and Protocol Case population – patients with FASD Disease control – patients with Williams syndrome Controls - Matched, unexposed subjects

Phenotypic Similarities in Three Disorders Williams syndrome Velocardiofacial syndrome Fetal alcohol syndrome Anticonvulsant embryopathies

Methods and Protocol Physical (morphological) examination Height, weight, head circumference Palpebral fissure length Maxillary and mandibular arcs Philtral assessment (Astley scores) Non-craniofacial measures (e.g., flexion creases of hands) Facial imaging

Facial Measurements Lengths Arcs Palpebral fissure Inner canthal distance Philtral length Arcs Maxillary Mandibular

Short Palpebral Fissures

Smooth Philtrum, Thin Upper Lip From Astley et al, 2000

Logistic Regression Modeling The best clinical measures that predicted FAS compared to Controls were palpebral fissure length, mandibular arc, and campodactyly. The overall likelihood ratio statistic for the model was 70.30, p<0.001 The best clinical measure that predicted FAS compared to WS was palpebral fissure length. The overall likelihood ratio statistic for the model was 21.89, p<0.001

Logistic Regression Modeling The best clinical measures that predicted Controls compared to WS were height centile, smooth philtrum, and camptodactyly. The overall likelihood ratio statistic for the model was 39.59, p<0.001.